Levels of Bcl-2 and P53 Are Altered in Superior Frontal and Cerebellar Cortices of Autistic Subjects

Cellular and Molecular Neurobiology

Volumn 23, Issue 6, 2003, Pages 945-952

  Araghi Niknam, Mohsen ^a   Fatemi, S Hossein ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bcl 2 autism; Cerebellum; P53; Superior frontal cortex; Western blotting

Indexed keywords

BETA ACTIN; PROTEIN BCL 2; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; AUTISM; CALCULATION; CEREBELLUM; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; HYPOTHESIS; MALE; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN FUNCTION; WESTERN BLOTTING;

ADULT; AUTISTIC DISORDER; CEREBELLAR CORTEX; FRONTAL LOBE; HUMANS; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; STATISTICS, NONPARAMETRIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0347355175     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CEMN.0000005322.27203.73     Document Type: Article

References (32)

1. Abell, E, et al. (1999). The neuroanatomy of autism. A voxel-based whole brain analysis of structural scans. Neuroreport. 10:1647-1651.
2. Afzal, M. A., and Minor, P. D. (2002). Vaccines, Crohn's disease and autism. Mol. Psychiatry 7 (Suppl 2):S49-S50.
3. Araki, N., et al. (2001). Comparative analysis of brain proteins from P53-deficient mice by two-dimensional electrophoresi. Electrophoresis 21:1880-1889.
4. Ashcroft, M., and Vousen, K. H. (1999). Regulation of P53 stability. Oncogene 13:18(53):7637-7643.
5. Barak, Y., et al. (1999). Autistic subjects with comorbid epilepsy: A possible association with viral infections. Child Psychiatry Hum. Dev. 29:(3):245-251.
6. Bauman, M. L., and Kemper, T. L. (1994). Neuroanatomic Observation of the Brain in Autism. The Neurobiology of Autism, John Hopkins University, Baltimore, 119-145.
7. Blatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., and Bauman, M. L. (2001). Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study. J. Aut. Dev. Dis. 31:537-543.
8. Bubser, M., and Koch, M. (1994). Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology 113:487-492.
9. Crnic, L. S., (2002). The Colorado mental retardation and developmental disabilities research center. Int. J. Dev. Neurosci. 20(3-5):297-299.
10. Fatemi, S. H., Halt, A. R., Stary, J. M., Realmuto, G., and Jalali Mousavi, M. (2001a). Reduction in antiapoptotic protein Bcl-2 in autistic cerebellum. NeuroReport 12:929-933.
11. Fatemi, S. H., Stary, J. M., Halt, A. R., and Realmuto, G. R. (2001b). Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum. J. Aut. Dev. D. 31:529-534.
12. Fatemi, S. H., and Halt, A. R. (2001). Altered levels of Bcl-2 and P53 proteins in parietal cortex reflect deranged apoptotic regulation in autism. Synapse 15:281-284.
13. Fatemi, S. H., Halt, A. R., Realmuto, G., Kist, D., Earle, J. A., and Thuras, P. (2002a). Reduced Purkinje cell size in autistic cerebellum. Cell Mol. Neurobiol. 22:171-175.
14. Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., and Realmuto, G. R. (2002b). Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52:805-810.
15. Gaffney, G. R., et al. (1987). Midsagittal magnetic resonance imaging of autism. Br. J. Psychiatry 151:831-833.
16. Jarskog. (2000). Cortical Bcl-2 protein-Expression and apoptotic regulation in schizophrenia. Biol. Psychiatry 48:641-650.
17. Jepsen, R. H., and VonThaden, K. (2002). The effect of cognitive education on the performance of students with neurological developmental disabilities. NeuroRehabilitation 17(3):201-209.
18. Lee, R. (2002). The effects of differential and lag reinforcement schedules on varied verbal responding by individuals with autism. J. Appl. Behav. Anal. 35(4):391-402.
19. Lee, M., Martin-Ruiz, C., Graham, A., Court, J., Jaros, E., Perry, R., Iverson, P., Bauman, M., and Perry, E. (2002). Nicotinic receptor adnormalities in the cerebellar cortex in autism. Brain 125:1483-1493.
20. Levitt, J. G. (1999). Cerebellar vermis lobules VIII-X in autism. Prog. Neuropsychopharmacol Biol. Psychiatry 23:625-633.
21. Loveland, K. A., et al. (2001). Judgments of social appropriateness by children and adolescents with autism. J. Autism Dev. Disord. 31:367-376.
22. Margolis, R. L. (1997). cDNAs with long CAG trinucleotide repeats from human brain. Hum. Genet. 100:114-122.
23. Miyashita, T. (1994). Tumor suppressor P53 is a regulator of Bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
24. Perry, E. K., Lee, M. L., Martin Ruiz, C. M., and Court, J. A. (2001). Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiatry 158:1058-1066.
25. Piven, J. (1992). Magnetic resonance imaging in autism. Measurement of the cerebellum, pons, and fourth ventricle. Biol. Psychiatry 31:491-504.
26. Purcell, A. E., Jeon O. H., Zimmerman, A. W., Blue, M. E., and Pevsner, J. (2001). Postmortem brain abnormalities of the glutamate neurotransmitter system in austim. Neurology 57:1618-1628.
27. Rapin, I. (1997). Autism. N. Engl. J Med. 337:97-104.
28. Reed, J. C. (1997). Double identity for proteins of the Bcl-2 family. Nature 387:773-776.
29. Sharova, L. (2000). Nonspecific stimulation of the maternal immune system II. Effects on gene expression in the fetus. Teratology 62:420-428.
30. Veenstra-Vanderweele, J. (2003). Genetics of childhood disorders: XLVI. Autism, part 5: Genetics of autism. J. Am. Acad. Child Adolesc. Psychiatry 42(1):116-118.
31. Warren, R. P. (1998). An immunologic theory for the development of some cases of autism. CNS Spectr. 3:71-79.
32. Wing, L. (1997). The autistic spectrum. Lancet 350:1761-1766.